William Blair Starts Agile Therapeutics (AGRX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Janney Starts Agile Therapeutics (AGRX) at Buy
June 17, 2014 7:23 AM EDTJanney Montgomery Scott initiated coverage on Agile Therapeutics (NASDAQ: AGRX) with a Buy rating and a price target of $18.00.
For an analyst ratings summary and ratings history on Agile Therapeutics click here. For more ratings news on Agile Therapeutics click here.
Shares of Agile Therapeutics closed at $6.78 yesterday.
... MoreCantor Fitzgerald Starts Agile Therapeutics (AGRX) at Buy
June 17, 2014 7:22 AM EDTCantor Fitzgerald initiated coverage on Agile Therapeutics (NASDAQ: AGRX) with a Buy rating and a price target of $17.00.
Analyst Irina Rivkind Koffler said, "Agile is developing Twirla, a Phase III, low-dose estrogen contraceptive patch... More
